Loading paragraph...
Today's Biggest Stock Losers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| MIMI | Mint Incorporation | $2.25 | -$2.07 | -47.92% | 2.2M | $108.1M | $2.25$13.69 |
| SRPT | Sarepta Therapeutics | $16.80 | -$7.65 | -31.29% | 540.8K | $2.4B | $10.42$138.81 |
| ICHR | Ichor | $16.03 | -$6.89 | -30.06% | 1.8M | $786.8M | $13.12$36.48 |
| JELD | Jeld-wen | $3.01 | -$1.19 | -28.33% | 5.5M | $358.7M | $2.31$11.66 |
| NOMA | Nomadar | $8.25 | -$3.25 | -28.26% | 55.6K | - | $2.00$57.70 |
| ARTL | Artelo Biosciences | $2.15 | -$0.85 | -28.23% | 6M | $3.4M | $2.08$28.60 |
| FLYE | Fly-E Group | $7.20 | -$2.80 | -28.00% | 72.7K | $189.0M | $7.20$166.00 |
| YSXT | Ysx Tech. | $2.01 | -$0.76 | -27.44% | 236.5K | $64.9M | $1.68$9.96 |
| ESLA | Estrella Immunopharma | $2.27 | -$0.79 | -25.74% | 704.1K | $113.1M | $0.70$3.15 |
| CJET | Chijet Motor | $2.91 | -$0.92 | -24.14% | 218.2K | $350.4M | $2.77$299.00 |
Related Articles
Featured Article
Is This Stock a Buy After Soaring by 20% in 1 Day?
Prosper Junior Bakiny|Jul 24, 2025
With Its Kpler Deal on the Rocks, Can Spire Stock Survive?
Rich Smith|Mar 16, 2025
If you pay close enough attention to conference calls, you just might find a stock that can double -- like Spire Global.
After a Big Win, Is Sarepta Therapeutics Stock a Buy?
Alex Carchidi|Jul 6, 2024
One key issue remains unresolved, and it could be a significant one.
Has Sarepta Therapeutics Become a No-Brainer Stock Buy After This Recent FDA News?
David Jagielski|Jul 4, 2024
The label expansion paves the way for much more revenue growth for Sarepta in the years ahead.
1 Soaring Growth Stock to Buy and Hold for 10 Years
Prosper Junior Bakiny|Jul 3, 2024
Let's look beyond the biotech's performance this year.
1 Top Growth Stock to Buy and Hold for 10 Years
Prosper Junior Bakiny|May 1, 2024
This company's lineup might look very different in a decade, but the end result will be the same for investors.
Does This 1 New Threat Make Sarepta Therapeutics Stock Worth Selling?
Alex Carchidi|Mar 13, 2024
The threat is still emerging, but it could be significant.
Sarepta Therapeutics Stock Has 73% Upside, According to 1 Wall Street Analyst
Alex Carchidi|Mar 4, 2024
The upcoming regulatory decision on its latest drug could be big.
Is It Too Late to Buy Sarepta Therapeutics Stock?
Prosper Junior Bakiny|Feb 28, 2024
The company's hyperfocus on its core area could continue to be highly lucrative.
2 Magnificent Growth Stocks to Buy With $500
Prosper Junior Bakiny|Feb 15, 2024
No need to break the bank to invest in promising stocks.
